expenditure for developing new dialysis products are expected to boost the growth of the renal dialysis market at a CAGR of 5.70% during the forecast period 2023 to 2032

Market Research Future (MRFR) has published on the “Global Renal Dialysis Market”.

The renal dialysis market is estimated to register a CAGR of 5.70% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the Renal dialysis Market— Becton, DICKINSON, and Company (US), B. Braun SE (Germany), Cantel Medica (US), Nipro Europe Group Companies (Belgium), Nikkiso Co., Ltd (Japan), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter (US), Medtronic (Ireland), Jordan Medical Solutions (Jordan), Asahi Kasei Corporation (Japan)

Renal Dialysis Market Highlights

The global renal dialysis market is expected to register a CAGR of 5.70% during the forecast period and is estimated to reach USD 30.47 billion by 2032.

The renal dialysis market is expected to be driven by growing prevalence of chronic kidney disease (CKD) and rising r&d expenditure for developing new dialysis products The global estimated prevalence of CKD is 13.4% (11.7-15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy is estimated between 4.902 and 7.083 million. Additionally, gaining momentum toward home hemodialysis and peritoneal dialysis will provide growth opportunities for the market in the future.

However, the high cost of dialysis treatment might hamper the market's growth in the forecast period.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Renal dialysis market 

Segment Analysis

The Renal dialysis market has been segmented based on type, product, and end-user.

On the basis of type, the market is segmented into primary dialysis and secondary dialysis. Primary dialysis includes hemodialysis, hemofiltration, and peritoneal dialysis. The primary dialysis segment accounted for the largest market share in 2022 due to the rising prevalence of chronic kidney diseases (CKD), the shortage of kidneys for transplantation, and technological advancements. As per the World Kidney Day 2022 Campaign, 1 in 10 people worldwide is diagnosed with CKD, and further, it revealed that kidney disease-related mortality is persistently increasing and that by 2040, it will be the 5th leading cause of death globally. Additionally, secondary dialysis includes hemodiafiltration (HDF) and intestinal dialysis. Secondary dialysis is a backup and rescue therapy for primary dialysis, and the factors influencing its growth are the benefits of HDF over hemodialysis and increasing awareness of HDF. Moreover, the rise in product launches is associated with technology-based hemodiafiltration.

On the basis of the product, the market is segmented into dialysis machines, dialyzers, dialysis concentrates, dialysis catheters, and others. In 2022, the Dialysis Machines segment dominated the market, holding the largest market share. It is also projected to be the fastest growing segment from 2023 to 2032. Dialysis machines play a crucial role in renal dialysis, commonly referred to as artificial kidney dialysis. Market players are introducing innovative dialysis machines suitable for all age groups, including adults and paediatrics. For example, in December 2020, Medtronic plc (Ireland) launched a specialized dialysis machine for pediatric and neonatal patients, which was successfully implemented at Cincinnati Children's Hospital Medical Centre (US). Additionally, dialyzers come in two types: single-use dialyzers and reuse dialyzers. The demand for dialyzers is consistently rising due to the prevalence of end-stage kidney disease, as it involves the presence of macro-sized proteins that can deteriorate the dialyzer within a short period of time.

On the basis of end users, the market is segmented into hospitals & clinics, dialysis centers, and home care settings. Hospitals & clinics dominated the market share in 2022 due to the high prevalence of CKD and AKD worldwide. The preference for hospitals & clinics for treating kidney diseases is mainly due to the presence of specialists and advanced dialysis products. Key players like Rockwell Medical, Inc. (US) and Fresenius Kabi AG (Germany) play a crucial role in this expanding market. Rockwell Medical, Inc. (US) caters to over 1700 dialysis clinics and is one of the two suppliers capable of servicing the vast number of dialysis clinics in the US and international markets in 2023. On the other hand, Fresenius Kabi AG (Germany) is a global leader in dialysis products and services, serving a significant number of patients in numerous clinics worldwide. The growth of dialysis centers is attributed to the availability of medical coverage from both private and government organizations.

Regional Analysis

The renal dialysis market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe renal dialysis market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The renal dialysis market Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The rest of the world renal dialysis service providers market comprises of Middle East, Africa, and Latin America.

The market for renal dialysis in North America has the most share (39.19%) in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.68% to reach over USD 10.94 billion by 2032. Renal dialysis is increasing in North America, with steady expansion predicted. Further market expansion is anticipated as a result of investments in healthcare infrastructure and rising public awareness of modern medical treatments. Thanks to technology improvements, both established businesses and newcomers are well-positioned to take advantage of these opportunities and address the growing need for better results.

The Europe renal dialysis’ market is currently undergoing substantial growth, driven by a confluence of factors that include technological advancements, an aging population, and a surge in chronic kidney diseases. This dynamic landscape is witnessing notable innovations in renal dialysis solutions, leading to enhanced efficacy and improved patient outcomes. The integration of advanced renal dialysis products ultimately leads to enhanced patient care. This transformative journey aligns with broader goals of advancing healthcare technologies and ensuring better outcomes, positioning Europe as a key player in the global market and contributing to the ongoing enhancement of healthcare delivery and patient well-being across the continent.

Furthermore, The Asia-pacific Renal dialysis market accounted for USD 4.35 billion in 2022 and is projected to grow at a CAGR of 7.23% during the forecast period. The Asia Pacific renal dialysis’ market is projected to experience significant growth in the coming years. Factors such as the increasing number of geriatric populations, rising prevalence of chronic kidney diseases, and technological advancements in dialysis procedures are expected to drive market growth. The market is also being expanded by the aging population, who are more likely to require surgical operations.

The market for Renal dialysis in the Rest of the World was valued at USD 1.50 billion in 2022 and is expected to grow with a compound annual growth rate (CAGR) of 6.12%. The Rest of the World market is divided into Middle East, Africa and Latin America. Renal dialysis is in high demand due to their important role in tackling chronic kidney diseases. Furthermore, the development of advanced technologies and continuous product innovation are driving the growth of the market, improving the overall effectiveness of medical solutions. In these regions, where the healthcare infrastructure is changing quickly, the use of haemostasis or tissue sealing agents is increasing due to increasing awareness of their advantages.

Key Findings of the Study

• The Renal dialysis market is expected to reach USD 30. 47 billion by 2032, at a CAGR of 5.70% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market.


• Based on product type, the dialysis machine ‘s segment was attributed to holding the largest market in 2022.


• Becton, DICKINSON, and Company (US), B. Braun SE (Germany), Cantel Medica (US), Nipro Europe Group Companies (Belgium), Nikkiso Co., Ltd (Japan), are top major players.